ENDOTAK/ENDURANCE/RELIANCE
FDA premarket approval P910073/S064 · decided 2006-05-11
Approval details
- PMA number
- P910073
- Supplement
- S064
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- ENDOTAK/ENDURANCE/RELIANCE
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2006-04-13
- Decision date
- 2006-05-11
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- CHANGES TO THE LIMULUS AMEBOCYTE LYSATE (LAL) SAMPLING PLAN.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.